Molecular profiling using our custom thyroid cancer gene panel revealed the molecular characteristics of this tumor, which showed additional mutations (KRAS and TERT‐p) in In‐N, indicating STc with malignant potential from the well‐differentiated Out‐N. The gene discussed is KRAS; the disease is neoplasm.